|
 | 嘉实医疗保健(000711)基金投资组合(持股) 年份： | | 截止日期 | 股票代码 | 股票名称 | 数量(万股) | 持有市值(万元) | 占基金资产净值比例(%) | | 2026-03-31 | 603259 | 药明康德 | 69.30 | 6798.61 | 9.24% | | 2026-03-31 | 600276 | 恒瑞医药 | 113.45 | 6264.90 | 8.52% | | 2026-03-31 | 688131 | 皓元医药 | 89.89 | 6229.94 | 8.47% | | 2026-03-31 | 688266 | 泽璟制药-U | 62.43 | 6168.53 | 8.38% | | 2026-03-31 | 002821 | 凯莱英 | 45.32 | 5020.10 | 6.82% | | 2026-03-31 | 688192 | 迪哲医药-U | 87.51 | 4742.20 | 6.45% | | 2026-03-31 | 300347 | 泰格医药 | 81.43 | 4383.55 | 5.96% | | 2026-03-31 | 300759 | 康龙化成 | 151.83 | 4248.27 | 5.77% | | 2026-03-31 | 688710 | 益诺思 | 55.05 | 3908.69 | 5.31% | | 2026-03-31 | 688293 | 奥浦迈 | 49.88 | 2144.65 | 2.92% | |
|